388 related articles for article (PubMed ID: 27497251)
21. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
Zhang H; Chambers W; Sciascia S; Cuadrado MJ
Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
[TBL] [Abstract][Full Text] [Related]
22. Post-marketing experiences with belimumab in the treatment of SLE patients.
Askanase AD; Yazdany J; Molta CT
Rheum Dis Clin North Am; 2014 Aug; 40(3):507-17, viii. PubMed ID: 25034159
[TBL] [Abstract][Full Text] [Related]
23. New therapeutic avenues in SLE.
Bakshi J; Ismajli M; Rahman A
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):794-809. PubMed ID: 27107514
[TBL] [Abstract][Full Text] [Related]
24. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
26. Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.
Poh YJ; Baptista B; D'Cruz DP
Expert Rev Clin Immunol; 2017 Oct; 13(10):925-938. PubMed ID: 28847197
[TBL] [Abstract][Full Text] [Related]
27. Update on belimumab for the management of systemic lupus erythematosus.
Lutalo PM; D'Cruz DP
Expert Opin Biol Ther; 2014 Nov; 14(11):1701-8. PubMed ID: 25303323
[TBL] [Abstract][Full Text] [Related]
28. Biologics in SLE: towards new approaches.
van Vollenhoven RF; Parodis I; Levitsky A
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):341-9. PubMed ID: 24238691
[TBL] [Abstract][Full Text] [Related]
29. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
Hachulla É
Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus erythematosus: still a challenge for physicians.
Bengtsson AA; Rönnblom L
J Intern Med; 2017 Jan; 281(1):52-64. PubMed ID: 27307107
[TBL] [Abstract][Full Text] [Related]
31. Update on Biologic Therapies for Systemic Lupus Erythematosus.
Borba HH; Funke A; Wiens A; Utiyama SR; Perlin CM; Pontarolo R
Curr Rheumatol Rep; 2016 Jul; 18(7):44. PubMed ID: 27299782
[TBL] [Abstract][Full Text] [Related]
32. Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?
Runkel L; Stacey J
Expert Opin Biol Ther; 2014 Apr; 14(4):491-501. PubMed ID: 24490627
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
Fattah Z; Isenberg DA
Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
[TBL] [Abstract][Full Text] [Related]
34. Belimumab for systemic lupus erythematosus: a practice-based view.
Parodis I; Axelsson M; Gunnarsson I
Lupus; 2013 Apr; 22(4):372-80. PubMed ID: 23553780
[TBL] [Abstract][Full Text] [Related]
35. Future prospects in biologic therapy for systemic lupus erythematosus.
Stohl W
Nat Rev Rheumatol; 2013 Dec; 9(12):705-20. PubMed ID: 24018550
[TBL] [Abstract][Full Text] [Related]
36. New and future therapies: Changes in the therapeutic armamentarium for SLE.
Askanase A; Khalili L; Tang W; Mertz P; Scherlinger M; Sebbag E; Chasset F; Felten R; Arnaud L
Best Pract Res Clin Rheumatol; 2023 Dec; 37(4):101865. PubMed ID: 37633826
[TBL] [Abstract][Full Text] [Related]
37. Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.
Wallace DJ; Navarra S; Petri MA; Gallacher A; Thomas M; Furie R; Levy RA; van Vollenhoven RF; Cooper S; Zhong ZJ; Freimuth W; Cervera R;
Lupus; 2013 Feb; 22(2):144-54. PubMed ID: 23213069
[TBL] [Abstract][Full Text] [Related]
38. Belimumab: review of use in systemic lupus erythematosus.
Boyce EG; Fusco BE
Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus erythematosus: an update.
Golder V; Hoi A
Med J Aust; 2017 Mar; 206(5):215-220. PubMed ID: 28301792
[TBL] [Abstract][Full Text] [Related]
40. New Trials in Lupus and where Are we Going.
Thanou A; Merrill JT
Curr Rheumatol Rep; 2018 May; 20(6):34. PubMed ID: 29725880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
